ArticleJAC-antimicrobial resistance2025
The environmental impact of intravenous antimicrobial therapies: a comparison of OPAT and inpatient administration care pathways.
Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Comparing Self-Administered Outpatient Parenteral Antimicrobial Therapy (S-OPAT) with Alternative Delivery Models: Risk Factors for Treatment Failure and Complications in a UK Cohort.Pathogens (Basel, Switzerland) · 2026Article
- Cost savings of outpatient parenteral antimicrobial therapy using a digital infusion pump.JAC-antimicrobial resistance · 2026Article
- Continuous infusion OPAT via elastomeric pumps: effectiveness, safety, and cost-saving potential in a real-world Italian cohort.Infection · 2026Article
- [Outpatient parenteral antimicrobial therapy: challenges and opportunities].Innere Medizin (Heidelberg, Germany) · 2026Article
- Comment on: The environmental impact of intravenous antimicrobial therapies: a comparison of OPAT and inpatient administration care pathways.JAC-antimicrobial resistance · 2025Article
- PO-llution control: a cross-sectional study on the role of antimicrobial stewardship in reducing healthcare's carbon footprint.JAC-antimicrobial resistance · 2025Article
- Delivery of Outpatient Parenteral Antimicrobial Therapy (OPAT) in an Ever-Changing National Health Service (UK): Benefits, Barriers, and Opportunities.Antibiotics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The urgent global threats of the climate crisis and antimicrobial resistance have the potential to be addressed in part by increasing the use of outpatient antimicrobial therapy (OPAT). Our study aimed to appraise the environmental impact of three commonly used OPAT pathways, and the traditional inpatient model of IV antimicrobial therapy. Methods: We assessed the CO Results: We found that the administration of IV antibiotics in hospital is associated with a substantial environmental impact compared to OPAT. When OPAT is self-administered in the patient's home, we discovered a CO Conclusions: Our study demonstrates that using OPAT reduces the environmental impact of delivering antimicrobial therapy compared to inpatient treatment. As it is delivered away from the hospital setting, it may also reduce the risks to health associated with inpatient care. While we have shown that the reduction in CO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.